Ligand Pharmaceuticals Inc (NASDAQ:LGND)

79.80
Delayed Data
As of May 01
 +2.16 / +2.78%
Today’s Change
41.99
Today|||52-Week Range
90.48
+49.97%
Year-to-Date

Today’s Trading

Previous close77.64
Today’s open78.42
Day’s range77.87 - 80.80
Volume381,018
Average volume (3 months)413,199
Market cap$1.6B
Dividend yield--
Data as of 3:59pm ET, 05/01/2015

Growth & Valuation

Earnings growth (last year)+31.55%
Earnings growth (this year)+38.82%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+31.78%
P/E ratio142.5
Price/Sales16.83
Price/Book59.35

Competitors

 Today’s
change
Today’s
% change
ADROAduro Biotech Inc+0.69+2.72%
SAGESAGE Therapeutics In...+1.64+3.09%
USNAUSANA Health Science...+6.49+5.71%
CMRXChimerix Inc+1.34+3.94%
Data as of 4:02pm ET, 05/01/2015

Financials

Next reporting dateMay 11, 2015
EPS forecast (this quarter)$0.27
Annual revenue (last year)$64.5M
Annual profit (last year)$12.0M
Net profit margin18.63%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John L. Higgins
President &
Chief Operating Officer
Matthew W. Foehr
Corporate headquarters
La Jolla, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers